Kabra Drugs Ltd. Income Statement
Industry Phar BSE Code 524322 Face Value 10.00
Chairman NSE Code KABRADG Market Lot 1
Group Not Applicable ISIN No INE323K01017 Book Closure 30/09/2024
You can view the Income statement for the last 5 years. (Rs. in Crs.)
ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
      
Other Income0.640.000.010.000.00
Total Revenue0.640.000.010.000.00
      
EXPENSES     
Employee Benefit Expenses0.690.400.230.090.05
Depreciation And Amortisation Expenses0.010.000.000.010.03
Other Expenses1.030.340.110.090.10
Total Expenses1.730.740.340.190.18
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax-1.09-0.74-0.34-0.19-0.18
      
Profit/Loss Before Tax-1.09-0.74-0.34-0.19-0.18
      
Tax Expenses-Continued Operations     
Profit/Loss After Tax And Before ExtraOrdinary Items-1.09-0.74-0.34-0.19-0.18
      
Profit/Loss From Continuing Operations-1.09-0.74-0.34-0.19-0.18
      
Profit/Loss For The Period-1.09-0.74-0.34-0.19-0.18
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)-0.99-1.66-0.77-0.42-0.41
Diluted EPS (Rs.)-0.99-1.66-0.77-0.42-0.41
  Company Info
Type first few letters